Abstract
The lifetime prevalence of panic disorder (PD) is up to 4% worldwide and there is substantial evidence that genetic factors contribute to the development of PD. Single-nucleotide polymorphisms (SNPs) in TMEM132D, identified in a whole-genome association study (GWAS), were found to be associated with PD in three independent samples, with a two-SNP haplotype associated in each of three samples in the same direction, and with a P-value of 1.2e−7 in the combined sample (909 cases and 915 controls). Independent SNPs in this gene were also associated with the severity of anxiety symptoms in patients affected by PD or panic attacks as well as in patients suffering from unipolar depression. Risk genotypes for PD were associated with higher TMEM132D mRNA expression levels in the frontal cortex. In parallel, using a mouse model of extremes in trait anxiety, we could further show that anxiety-related behavior was positively correlated with Tmem132d mRNA expression in the anterior cingulate cortex, central to the processing of anxiety/fear-related stimuli, and that in this animal model a Tmem132d SNP is associated with anxiety-related behavior in an F2 panel. TMEM132D may thus be an important new candidate gene for PD as well as more generally for anxiety-related behavior.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hettema JM, Neale MC, Kendler KS . A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001; 158: 1568–1578.
Kessler RC, Berglund P, Demler O, Jin R, Walters EE . Lifetime prevalence and age-of-onset distributions’ of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005; 62: 593–602.
Kendler KS, Gardner CO, Prescott CA . Panic syndromes in a population-based sample of male and female twins. Psychol Med 2001; 31: 989–1000.
Gelernter J, Bonvicini K, Page G, Woods SW, Goddard AW, Kruger S et al. Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am J Med Genet 2001; 105: 548–557.
Smoller JW, Acierno JS, Rosenbaum JF, Biederman J, Pollack MH, Meminger S et al. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am J Med Genet 2001; 105: 195–206.
Middeldorp CM, Hottenga JJ, Slagboom PE, Sullivan PF, de Geus EJ, Posthuma D et al. Linkage on chromosome 14 in a genome-wide linkage study of a broad anxiety phenotype. Mol Psychiatry 2007; 13: 84–89.
Fullerton J, Cubin M, Tiwari H, Wang C, Bomhra A, Davidson S et al. Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism. Am J Hum Genet 2003; 72: 879–890.
Gratacos M, Sahun I, Gallego X, Amador-Arjona A, Estivill X, Dierssen M . Candidate genes for panic disorder: insight from human and mouse genetic studies. Genes Brain Behav 2007; 6: 2–23.
Skol AD, Scott JS, Abecasis GR, Boehnke M . Optimal design for two-stage genome-wide association studies. Genet Epidemiol 2007; 31: 776–788.
Kromer SA, Kessler MS, Milfay D, Birg IN, Bunck M, Czibere L et al. Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 2005; 25: 4375–4384.
Kessler MS, Murgatroyd C, Bunck M, Czibere L, Frank E, Jacob W et al. Diabetes insipidus and, partially, low anxiety-related behaviour are linked to a SNP-associated vasopressin deficit in LAB mice. Eur J Neurosci 2007; 26: 2857–2864.
Bunck M, Czibere L, Horvath C, Graf C, Frank E, Kessler MS et al. A hypomorphic vasopressin allele prevents anxiety-related behavior. PLoS ONE 2009; 4: e5129.
Bandelow B . Panic and Agoraphobia Scale (PAS). Hogrefe & Huber Publishers: Göttingen, Bern, Toronto, Seattle, 1999.
Hamilton M . The assessment of anxiety-states by rating. Br J Med Psychol 1959; 32: 50–55.
Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.
Wittchen HU, Pfister H . DIA-X-Interviews: Manual für Screening-Verfahren und Interview. Swets & Zeitlinger: Frankfurt, 1997.
Steinlein OK, Deckert J, Nothen MM, Franke P, Maier W, Beckmann H et al. Neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) and panic disorder: an association study. Am J Med Genet 1997; 74: 199–201.
Sand PG, Mori T, Godau C, Stober G, Flachenecker P, Franke P et al. Norepinephrine transporter gene (NET) variants in patients with panic disorder. Neurosci Let 2002; 333: 41–44.
Fangerau H, Ohlraun S, Granath RO, Nothen MM, Rietschel M, Schulze TG . Computer-assisted phenotype characterization for genetic research in psychiatry. Hum Hered 2004; 58: 122–130.
Steffens M, Lamina C, Illig T, Bettecken T, Vogler R, Entz P et al. SNP-based analysis of genetic substructure in the German population. Hum Hered 2006; 62: 20–29.
Lieb R, Isensee B, von Sydow K, Wittchen HU . The Early Developmental Stages of Psychopathology Study (EDSP): a methodological update. Eur Addict Res 2000; 6: 170–182.
Bandelow B . Assessing the efficacy of treatments for panic disorder and agoraphobia .2. The panic and agoraphobia scale. Int Clin Psychopharmacol 1995; 10: 73–81.
Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004; 36: 1319–1325.
Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R et al. Genome-wide associations of gene expression variation in humans. PloS Genet 2005; 1: 695–704.
Myers AJ, Gibbs JR, Awebster J, Rohrer K, Zhao A, Marlowe L et al. A survey of genetic human cortical gene expression. Nat Genet 2007; 39: 1494–1499.
Palkovits M . Isolated removal of hypothalamic or other brain nuclei of rat. Brain Res 1973; 59: 449–450.
Paxinos G, Franklin K . The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, San Francisco, New York, Boston, London, Sydney, Tokyo, 2001.
Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(−Delta Delta C) method. Methods 2001; 25: 402–408.
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225–2229.
Dunning M, Smith M, Thorne N, Tavaré S . An R package to analyse Illumina BeadArrays. R News 2006; 6: 17–23.
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D . Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904–909.
Landgraf R, Kessler MS, Bunck M, Murgatroyd C, Spengler D, Zimbelmann M et al. Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I. Neurosci Biobehav Rev 2007; 31: 89–102.
Cheeta S, Kenny PJ, File SE . Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog Neuro-Psychopharmacol Biol Psychiatry 2000; 24: 1053–1067.
Carobrez AP, Teixeira KV, Graeff FG . Modulation of defensive behavior by periaqueductal gray NMDA/glycine-B receptor. Neurosci Biobehav Rev 2001; 25: 697–709.
Salchner P, Sartori SB, Sinner C, Wigger A, Frank E, Landgraf R et al. Airjet and FG-7142-induced Fos expression differs in rats selectively bred for high and low anxiety-related behavior. Neuropharmacol 2006; 50: 1048–1058.
Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN . Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177–182.
Dudbridge F, Gusnanto A . Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 2008; 32: 227–234.
Sullivan PF, de Geus EJ, Willemsen G, James MR, Smit JH, Zandbelt T et al. Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry 2009; 14: 359–375.
Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, Kong XQ et al. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 2008 e-pub ahead of print.
Otowa T, Yoshida E, Sugaya N, Yasuda S, Nishimura Y, Inoue K et al. Genome-wide association study of panic disorder in the Japanese population. J Hum Genet 2009; 54: 122–126.
Consortium TWTCC . Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661–678.
Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2007; 13: 197–207.
Gupta AR, State MW . Recent advances in the genetics of autism. Biol Psychiatry 2007; 61: 429–437.
Riley B, Kendler KS . Molecular genetic studies of schizophrenia. Eur J Hum Genet 2006; 14: 669–680.
Smith DJ, Lusis AJ . The allelic structure of common disease. Hum Mol Genet 2002; 11: 2455–2461.
Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007; 39: 1000–1006.
Skol AD, Scott LJ, Abecasis GR, Boehnke M . Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38: 209–213.
Roberts RG, Gardner RJ, Bobrow M . Searching for the 1 in 2 400 000: a review of dystorphin gene point mutations. Hum Mutat 1994; 4: 1–11.
U M, Shen L, Oshida T, Miyauchi J, Yamada M, Miyashita T . Identification of novel direct transcriptional targets of glucocorticoid receptor. Leukemia 2004; 18: 1850–1856.
Hubler TR, Scammell JG . Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 2004; 9: 243–252.
Coplan JD, Lydiard RB . Brain circuits in panic disorder. Biol Psychiatry 1998; 44: 1264–1276.
Ohman A . The role of the amygdala in human fear: automatic detection of threat. Psychoneuroendocrinol 2005; 30: 953–958.
Milad MR, Quirk GJ, Pitman RK, Orr SP, Fischl B, Rauch SL . A role for the human dorsal anterior cingulate cortex in fear expression. Biol Psychiatry 2007; 62: 1191–1194.
Straube T, Mentzel HJ, Miltner WHR . Waiting for spiders: brain activation during anticipatory anxiety in spider phobics. Neuroimage 2007; 37: 1427–1436.
Hasler G, Fromm S, Alvarez RP, Luckenbaugh DA, Drevets WC, Grillon C . Cerebral blood flow in immediate and sustained anxiety. J Neurosci 2007; 27: 6313–6319.
Etkin A, Wager TD . Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 2007; 164: 1476–1488.
Mobbs D, Petrovic P, Marchant JL, Hassabis D, Weiskopf N, Seymour B et al. When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science 2007; 317: 1079–1083.
Nagase T, Kikuno R, Ohara O . Prediction of the coding sequences of unidentified human genes. XXII. The complete sequences of 50 new cDNA clones which code for large proteins. DNA Res 2001; 8: 319–327.
Nomoto H, Yonezawa T, Itoh K, Ono K, Yamamoto K, Oohashi T et al. Molecular cloning of a novel transmembrane protein MOLT expressed by mature oligodendrocytes. J Biochem 2003; 134: 231–238.
Acknowledgements
We thank G Ernst-Jansen, G Gajewsky, J Huber, E Kappelmann, S Sauer, S Damast, M Koedel, M Asmus and A Sangl for their excellent technical support. We also thank Rene Breuer from the Central Institute of Mental Health from Mannheim for excellent management of the blood and phenotypic database. Katharina Domschke and Jürgen Deckert were supported by the Deutsche Forschungsgemeinschaft (SFB-TRR-58 C2 and Z2). We thank the NGFN for a grant enabling the genotyping of PopGen subjects within the second round of funding. We thank further the NGFN MooDs and the Max Planck Excellence Foundation for grant support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflicts of interest.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Supplementary information
Rights and permissions
About this article
Cite this article
Erhardt, A., Czibere, L., Roeske, D. et al. TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry 16, 647–663 (2011). https://doi.org/10.1038/mp.2010.41
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2010.41
Keywords
This article is cited by
-
Immunoglobulin genes expressed in lymphoblastoid cell lines discern and predict lithium response in bipolar disorder patients
Molecular Psychiatry (2023)
-
Effects of stressful life-events on DNA methylation in panic disorder and major depressive disorder
Clinical Epigenetics (2022)
-
Using coding and non-coding rare variants to target candidate genes in patients with severe tinnitus
npj Genomic Medicine (2022)
-
The C. elegans homolog of human panic-disorder risk gene TMEM132D orchestrates neuronal morphogenesis through the WAVE-regulatory complex
Molecular Brain (2021)
-
Compositional Features and Codon Usage Pattern of Genes Associated with Anxiety in Human
Molecular Neurobiology (2020)